Skip to main content
Top
Published in: Lung 6/2008

01-12-2008

Effects of 3-week Outpatient Pulmonary Rehabilitation on Exercise Capacity, Dyspnea, and Quality of Life in COPD

Authors: Andreas von Leupoldt, Erika Hahn, Karin Taube, Stephan Schubert-Heukeshoven, Helgo Magnussen, Bernhard Dahme

Published in: Lung | Issue 6/2008

Login to get access

Abstract

The effects of intensive 3-week outpatient pulmonary rehabilitation (PR) on exercise capacity, dyspnea, and health-related quality of life (HRQL) were investigated in patients with COPD. Two hundred ten patients with COPD (mean FEV1 = 54%pred) underwent PR consisting of exercise training, patient and psychosocial education, breathing and relaxation therapy, nutrition counseling, and smoking cessation support. Before and after PR, exercise capacity was assessed with 6-min walking tests (6MWT) and constant cycle ergometer exercise (CEE). Dyspnea was measured after 6MWTs with a Borg scale and after PR with the Transition Dyspnoea Index (TDI). HRQL was examined with the Medical Outcomes Study Short Form 36 (SF-36). Results showed improvements in the 6MWT (+39 m, p < 0.001) and CEE (+241 W × min, p < 0.001) after PR, paralleled by decreased dyspnea during the 6MWT (−0.5, p < 0.001) and during activities (TDI score = 3.6). Increases in all SF-36 subscales reflected improved HRQL after PR (p < 0.001). No gender differences were found. Patients with milder versus more severe COPD improved similarly in most outcomes. Regression analyses revealed that TDI scores were the most important predictor of improvements in HRQL. The results suggest that intensive 3-week outpatient PR is associated with improvements in exercise capacity, dyspnea, and HRQL in male and female patients with COPD irrespective of COPD severity. Reduced dyspnea during activities contributed the most to improvements in HRQL.
Literature
1.
go back to reference National Institutes of Health (2005) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, Publ. No. 2701 National Institutes of Health (2005) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, Publ. No. 2701
2.
go back to reference Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R (2006) Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27:188–207PubMedCrossRef Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R (2006) Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27:188–207PubMedCrossRef
3.
go back to reference Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27:397–412PubMedCrossRef Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27:397–412PubMedCrossRef
4.
go back to reference Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442PubMedCrossRef Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442PubMedCrossRef
5.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T, ATS/ERS Pulmonary Rehabilitation Writing Committee (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173:1390–1413PubMedCrossRef Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T, ATS/ERS Pulmonary Rehabilitation Writing Committee (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173:1390–1413PubMedCrossRef
6.
go back to reference Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C (2007) Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 131(5 Suppl):4S–42SPubMedCrossRef Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C (2007) Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 131(5 Suppl):4S–42SPubMedCrossRef
7.
go back to reference Reardon J, Casaburi R, Morgan M, Nici L, Rochester C (2005) Pulmonary rehabilitation for COPD. Respir Med 99(Suppl B):S19–S27PubMedCrossRef Reardon J, Casaburi R, Morgan M, Nici L, Rochester C (2005) Pulmonary rehabilitation for COPD. Respir Med 99(Suppl B):S19–S27PubMedCrossRef
8.
go back to reference Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4:CD003793PubMed Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4:CD003793PubMed
9.
go back to reference Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH (2006) Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 129:899–904PubMedCrossRef Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH (2006) Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 129:899–904PubMedCrossRef
10.
go back to reference Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, National Emphysema Treatment Trial Research Group (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128:3799–3809PubMedCrossRef Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, National Emphysema Treatment Trial Research Group (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128:3799–3809PubMedCrossRef
11.
go back to reference Verrill D, Barton C, Beasley W, Lippard WM (2005) The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 128:673–683PubMedCrossRef Verrill D, Barton C, Beasley W, Lippard WM (2005) The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 128:673–683PubMedCrossRef
12.
go back to reference de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121:1092–1098PubMedCrossRef de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121:1092–1098PubMedCrossRef
13.
go back to reference Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D, Clini E (2005) Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest 127:105–109PubMedCrossRef Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D, Clini E (2005) Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest 127:105–109PubMedCrossRef
14.
go back to reference Hui KP, Hewitt AB (2003) A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 124:94–97PubMedCrossRef Hui KP, Hewitt AB (2003) A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 124:94–97PubMedCrossRef
15.
go back to reference Skumlien S, Skogedal EA, Bjortuft O, Ryg MS (2007) Four weeks’ intensive rehabilitation generates significant health effects in COPD patients. Chron Respir Dis 4:5–13PubMedCrossRef Skumlien S, Skogedal EA, Bjortuft O, Ryg MS (2007) Four weeks’ intensive rehabilitation generates significant health effects in COPD patients. Chron Respir Dis 4:5–13PubMedCrossRef
16.
go back to reference Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85:751–758PubMedCrossRef Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85:751–758PubMedCrossRef
17.
go back to reference Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R (2007) Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 29:390–417PubMedCrossRef Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R (2007) Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 29:390–417PubMedCrossRef
18.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef
19.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40
20.
go back to reference American Thoracic Society (2002) Guidelines for the six minute walk test. Am J Respir Crit Care Med 166:111–117 American Thoracic Society (2002) Guidelines for the six minute walk test. Am J Respir Crit Care Med 166:111–117
21.
go back to reference Borg G (1998) Borg’s perceived exertion and pain scales. Human Kinetics Publishers, Champaign, IL Borg G (1998) Borg’s perceived exertion and pain scales. Human Kinetics Publishers, Champaign, IL
22.
go back to reference Ware JE, Sherbourne CD (1992) The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef Ware JE, Sherbourne CD (1992) The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
23.
go back to reference Hu J, Meek P (2005) Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung 34:415–422PubMedCrossRef Hu J, Meek P (2005) Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung 34:415–422PubMedCrossRef
24.
go back to reference Mahler DA, Mackowiak JI (1995) Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 107:1585–1589PubMedCrossRef Mahler DA, Mackowiak JI (1995) Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 107:1585–1589PubMedCrossRef
25.
go back to reference Boueri FM, Bucher-Bartelson BL, Glenn KA, Make BJ (2001) Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD. Chest 119:77–84PubMedCrossRef Boueri FM, Bucher-Bartelson BL, Glenn KA, Make BJ (2001) Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD. Chest 119:77–84PubMedCrossRef
26.
go back to reference Miyahara N, Eda R, Takeyama H, Kunichika N, Moriyama M, Aoe K, Kohara H, Chikamori K, Maeda T, Harada M (2000) Effects of short-term pulmonary rehabilitation on exercise capacity and quality of life in patients with chronic obstructive pulmonary disease. Acta Med Okayama 54:179–184PubMed Miyahara N, Eda R, Takeyama H, Kunichika N, Moriyama M, Aoe K, Kohara H, Chikamori K, Maeda T, Harada M (2000) Effects of short-term pulmonary rehabilitation on exercise capacity and quality of life in patients with chronic obstructive pulmonary disease. Acta Med Okayama 54:179–184PubMed
27.
go back to reference Bowen JB, Votto JJ, Thrall RS, Haggerty MC, Stockdale-Woolley R, Bandyopadhyay T, ZuWallack RL (2000) Functional status and survival following pulmonary rehabilitation. Chest 118:697–703PubMedCrossRef Bowen JB, Votto JJ, Thrall RS, Haggerty MC, Stockdale-Woolley R, Bandyopadhyay T, ZuWallack RL (2000) Functional status and survival following pulmonary rehabilitation. Chest 118:697–703PubMedCrossRef
28.
go back to reference Cote CG, Celli BR (2005) Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26:630–636PubMedCrossRef Cote CG, Celli BR (2005) Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26:630–636PubMedCrossRef
29.
go back to reference Mahler DA, Faryniarz K, Tomlinson D, Colice GL, Robins AG, Olmstead EM, O’Connor GT (1992) Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest 102:395–401PubMedCrossRef Mahler DA, Faryniarz K, Tomlinson D, Colice GL, Robins AG, Olmstead EM, O’Connor GT (1992) Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest 102:395–401PubMedCrossRef
30.
go back to reference Berry MJ, Rejeski WJ, Adair NE, Ettinger WH Jr, Zaccaro DJ, Sevick MA (2003) A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 23:60–68PubMedCrossRef Berry MJ, Rejeski WJ, Adair NE, Ettinger WH Jr, Zaccaro DJ, Sevick MA (2003) A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 23:60–68PubMedCrossRef
31.
go back to reference Green RH, Singh SJ, Williams J, Morgan MDL (2001) A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 56:143–145PubMedCrossRef Green RH, Singh SJ, Williams J, Morgan MDL (2001) A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 56:143–145PubMedCrossRef
32.
go back to reference Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinc E (2007) Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung 185:221–225PubMedCrossRef Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinc E (2007) Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung 185:221–225PubMedCrossRef
33.
go back to reference Nici L (2007) Can we make it last? maintaining benefits achieved with pulmonary rehabilitation. Lung 185:241–242PubMedCrossRef Nici L (2007) Can we make it last? maintaining benefits achieved with pulmonary rehabilitation. Lung 185:241–242PubMedCrossRef
Metadata
Title
Effects of 3-week Outpatient Pulmonary Rehabilitation on Exercise Capacity, Dyspnea, and Quality of Life in COPD
Authors
Andreas von Leupoldt
Erika Hahn
Karin Taube
Stephan Schubert-Heukeshoven
Helgo Magnussen
Bernhard Dahme
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Lung / Issue 6/2008
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-008-9089-3

Other articles of this Issue 6/2008

Lung 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.